Fundraising reflects continued scaling of the private credit platform’s middle-market direct lending strategy

WEST PALM BEACH, Fla., Aug. 3, 2026 — Manulife | Comvest Credit Partners, the private credit platform of Manulife Wealth & Asset Management, today announced that it has raised $5.4 billion of total investable capital in connection with the final close of Comvest Credit Partners VII (“CCP VII”) and related transaction vehicles, marking the largest fundraise to date for the platform.

CCP VII, the latest vintage of the platform’s flagship North American direct lending strategy, is designed to capitalize on opportunities across the middle market through a flexible, multi-faceted investment approach. The strategy invests across both cash flow and asset-based lending opportunities for sponsored and non-sponsored companies, aiming to dynamically allocate capital to attractive relative value opportunities as market conditions evolve.

“CCP VII builds on the momentum we’ve established over the past 20 years,” said Robert O’Sullivan, Global Head of Manulife | Comvest Credit Partners. “Rather than competing in the most broadly syndicated segments of the market, we focus on differentiated lending opportunities where complexity, structuring expertise, and relationship-driven origination create the potential for compelling risk-adjusted returns.”

CCP VII is already substantially deployed, demonstrating the strength and consistency of the platform’s origination engine and its ability to efficiently deploy capital while maintaining investment selectivity. CCP VII attracted commitments from both existing and new institutional investors, reflecting the continued confidence of the platform’s long-standing limited partner base while broadening its global investor relationships.

“This milestone reflects the sustained demand we’re seeing for private credit, particularly for scaled platforms in the middle market,” said Anne Valentine Andrews, Global Head of Private Markets at Manulife Investment Management. “In a dynamic market environment, institutional investors are increasingly focused on managers with the breadth of platform, sourcing capabilities, and discipline to deploy capital effectively and who seek to consistently deliver for clients. We believe through the Manulife | Comvest Credit Partners platform, we are well positioned to meet that demand, and we are grateful for the strong support CCP VII received from both existing and new limited partners.”

About Manulife | Comvest Credit Partners

Manulife | Comvest Credit Partners is a private credit platform with $21.5 billion¹ of assets under management that combines the private credit expertise and specialized capabilities of Manulife Investment Management and Comvest Credit Partners, bringing together scale, permanence, and deep market knowledge. The platform provides creative and flexible financing solutions to both sponsored and non-sponsored companies. Alongside Manulife Investment Management’s $24 billion¹ private equity program and global distribution network, the platform offers a full spectrum of private credit, supported by deep origination channels, rigorous underwriting discipline, and the financial strength of one of the world’s largest global insurers. For more information, please visit https://www.comvest.com.

About Manulife Wealth & Asset Management

As part of Manulife Financial Corporation, Manulife Wealth & Asset Management’s mission is to make decisions easier and lives better by helping people invest confidently to pursue a more secure financial future. Our strength comes from the diversity of our global asset management expertise and distribution capabilities. Our global investment teams span equities, fixed income, alternative credit, private markets, and multi-asset solutions. We provide investment, financial advice, and retirement plan services to millions of individuals, institutions, and retirement plan members worldwide. At the heart of our approach are three cultural pillars: Partner for Progress, Trust through Transparency, and Intellectual Curiosity. These values shape how we build long-term relationships, develop differentiated investment strategies, and empower advisors and clients to seek meaningful financial outcomes. Whether through cutting-edge technology, AI innovation, personalized advice, or sustainable stewardship, Manulife Wealth & Asset Management is a trusted partner helping clients navigate complexity and invest with confidence.

Not all offerings are available in all jurisdictions. For additional information, please visit manulifeim.com.

Media Inquiries
Gabriel Morales
[email protected]

SOURCE Manulife Wealth & Asset Management

State-supported medical device company invites Alabama hand surgeons to experience homegrown orthopedic innovation

MOBILE, Ala., July 31, 2026 — Simparo Inc. (DBA Simparo Surgical), an Alabama medical device company backed by an investment from Innovate Alabama, and supported by Hatch Fairhope, today announced the issuance of its fourth U.S. patent, U.S. Patent No. 12,661,103, granted June 23, 2026. The milestone underscores the strength of Alabama’s growing innovation economy and Simparo’s commitment to building advanced orthopedic technology in the state.

The newly issued patent addresses a long-standing challenge in Thumb CMC reconstruction: achieving basal joint reconstruction quickly, securely, and reproducibly. Conventional approaches often require second site tendon harvesting, drilling tunnels in the bone, and tensioning methods relying solely on approximation — steps that can add time and complexity to a procedure. Simparo’s suture-locking mechanism, the Falcon Suture Clutch, uses a one-way cinching design that lets a surgeon complete the repair to the desired tension in a controlled and incremental fashion.

“We’re proud to be an Alabama company, and proud of the support that Innovate Alabama and Hatch Fairhope has placed behind our vision,” said Chris Harber, CEO of Simparo Surgical. “This patent is a milestone not just for our team, but for what Alabama is building: a place where medical innovation is developed, protected, and delivered to the surgeons and patients who need it.”

For Alabama’s hand surgeons, the message is simple, we’re a locally grown, state-supported company producing protected, differentiated technology designed for the procedures they perform every day and for the Alabama patients they serve every day. Simparo’s portfolio now spans four issued patents covering its novel suture tensioning system and soon to be family of applications across the orthopedic field.

“We’d love to support Alabama surgeons by providing them with technological advancements to help treat their patients,” added Chris Harber. “When you choose Simparo, you’re choosing innovation that was built right here at home — and helping demonstrate what Alabama’s investment in companies like ours can achieve.”

About Innovate Alabama

Innovate Alabama is Alabama’s first statewide public-private partnership focused on small businesses, technology and innovation with a mission to help innovators grow roots here in Alabama. Innovate Alabama was established to implement the initiatives and recommendations set forth in the Alabama Innovation Commission’s report, including smart policy solutions that will create a more resilient and robust economy to remain competitive in a 21st-century world. With founding CEO Cynthia Crutchfield leading the charge, Innovate Alabama is also made up of a board of 11 innovation leaders appointed by Gov. Ivey, collaborating across sectors to advance industries, drive technology and facilitate an environment where innovation and small businesses thrive. Learn more about Innovate Alabama at www.innovatealabama.org.

About Hatch Fairhope

Hatch Fairhope is a dedicated business resource hub located in Downtown Fairhope, AL, for technology-based entrepreneurs in Baldwin County. Its mission is to support new and existing startups by providing access to resources, training, and networking opportunities to help them grow.

About Simparo Inc.

Simparo Inc. is a medical device company, headquartered in Mobile, AL focused on developing novel orthopedic devices and surgical methods for the upper and lower extremity that simplify surgical procedures, without sacrificing stability and improving the patient experience.

Media Contact:
Wendy Hebert | [email protected]

SOURCE Simparo Surgical